GMMMG logo

NHS photos

NHS logo

News

<< Back

News Summary

From this page you will be able to access a summary of additions or changes to the GMMMG website during March 2018

March 2018 

Formulary and Managed Entry Subgroup (FMESG)

19.3.18

The GMMMG DNP and Grey list has been updated in line with the guidance issued by NHSE “Items which should not be routinely prescribed in primary care: Guidance for CCGs”

GMMMG

2.3.18

The GM Clinical Standards Board recently recommended the Greater Manchester botulinum toxin commissioning policy for use across GM. The purpose of this policy is to ensure standardised availability of botulinum toxin within the NHS in GM and allow transparency in the management of this drug in evidence based and cost effective manner. The approach of this policy is pragmatic and recognises the widespread use of botulinum toxin in many specialties and the fact that treatment may continue long term.

<< Back

Line

TERMS AND CONDITIONS    |    CONTACT US    |    ABOUT US    |    ARCHIVE

RSS Feed
 
spacer